Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Sanders (INV-002022): HIV Trimer Immunogens to Elicit bNAbs Against Multiple Epitopes |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays completed |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
NA
Description
CAVD 884 is a pre-clinical rabbit study to investigate the immunogenicity of multiple Clade B SOSIP trimers, either as soluble trimers or presented on I53-50 nanoparticles.
Sign in to see full information about this study and to download study data.
Products
AMC011 SOSIP AMC011 SOSIP-I53-50NP AMC008/AMC009/AMC011/AMC016/TRO11 SOSIP trimer cocktail AMC008/AMC009/AMC011/AMC016/TRO11 SOSIP-I53-50NP cocktail AMC008+AMC009+AMC011+AMC016+TRO11 SOSIP-I53-50NP AMC008+AMC009+AMC011+AMC016+TRO11 SOSIP/C3d-I53-50NPIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.